Haafor (Singapore)’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,370
Closed -$205K 240
2019
Q4
$205K Buy
+3,370
New +$205K 0.14% 236